Cadrenal Therapeutics, Inc. vs Phase Genomics
Side by side, from the public record each company was imported from. Where a figure is missing it is because no source we hold states it — not because it is zero.
Phase Genomics is the older of the two, founded in 2015 — 7 years before Cadrenal Therapeutics, Inc..
- Founded
- 2022
- 2015
- Status
- Active
- Active
- Headquarters
- Ponte Vedra, United States
- Seattle, United States
- Industry
- Biotechnology
- biotechnology
- Founders
- Quang Pham, Matthew Szot, Douglas Losordo, Glynn Wilson, STEVEN ZELENKOFSKE, John Murphy, Steven W. Zelenkofske, Jeff W. Cole, Glynn W. Wilson, Douglas W. Losordo, Robert W. Lisicki, John R. Murphy, LEE S. GOLDEN, MATTHEW K. SZOT, JEFFREY K. COLE, QUANG X. PHAM, JAMES J. FERGUSON, GLYNN J. WILSON, STEVEN J. ZELENKOFSKE, James X. Ferguson, Matthew X. Szot, Lee R. Golden, Glynn R. Wilson, Steven R. Zelenkofske, Jeffrey X. Cole
- Ivan Liachko
- Legal form
- Incorporated in Delaware
- Not recorded
- Listed on
- Nasdaq
- Not recorded
- Ticker
- CVKD
- Not recorded
Facts on both companies come from the public records named on Cadrenal Therapeutics, Inc. and Phase Genomics.